List view / Grid view
Join Rey Mali and Félix Montero-Julian as they discuss the challenges facing the manufacture and QC of advanced therapy medicinal products (ATMPs) and potential solutions.
This webinar considers the fundamental importance of water system control within pharma processing and the best control and monitoring practices.
This whitepaper explores vaccine development during a pandemic, a response to complex challenges that traditional manufacturing methods will not solve.
The Gates Biomanufacturing Facility announced a strategic agreement with Nkarta to manufacture Nkarta's investigational cell therapy NKX101.
The biopharmaceutical industry performed significantly above average in EcoAct’s Climate Reporting Performance analysis – but what steps are big pharma companies taking to improve sustainability and how much further do they need to go?
Telstar promotes innovative aseptic production solutions in a setting marked by the new GMP Annex 1.
Researchers review how miniaturised process analytical technologies (PAT), microfluidic affinity assays and microchip capillary electrophoresis, enhance bioprocess monitoring and control.
In this webinar, discover how an innovative 2-in-1 method for material analysis accelerates visual and chemical particle analysis in the pharmaceutical industry.
This flyer explains step-by-step how to perform your root cause analysis more efficiently, reliably and cost-effectively with a 2-in-1 solution for visual and chemical particle analysis.
Everything you need to have confidence and compliance in your nitrosamine impurity analysis.
In this eGuide you will learn about an innovative 2-in-1 method for materials analysis and how your analysis for contamination identification and root cause analysis will benefit.
Machine vision-based concentration determination enabled the accurate real-time monitoring and control of continuous powder blending.
This article presents the findings from a study to establish optimum formulation parameters for effective effervescent vitamin C tablet production.
New research shows co-processed excipient is superior to non-co-processed when using near infrared (NIR) process analytical technology (PAT) to monitor direct compression tableting.
The biopharmaceutical industry is driven by the need to increase production and reduce costs, while maintaining product quality – and has increasingly been focused on intensification of processes to accomplish this goal. In this article, European Pharmaceutical Review’s Hannah Balfour summarises the potential benefits of implementing continuous bioprocessing and manufacturing…
